- ISIN
- US12637N2045
- Sector
- Healthcare
- Industry
- Biotechnology
Highlights
- Market Cap
- $19.33B
- Enterprise Value
- $31.47B
- EPS (TTM)
- $4.30
- PE Ratio
- 4.62
- PEG Ratio
- 0.66
- Total Revenue (TTM)
- $30.52B
- Gross Profit (TTM)
- $15.22B
- EBITDA (TTM)
- $9.90B
- Year Range
- $16.01 - $44.86
- Target Price
- $307.00
- ROA (TTM)
- 11.03%
- ROE (TTM)
- 22.41%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
CSLLY Performance Chart
CSL Ltd (CSLLY) is down 29.2% since the beginning of the year. At $20 per share, CSLLY is trading 55.7% below its 52-week high of $45. Investors who bought $1,000 worth of CSLLY shares 5 years ago would now be looking at an investment worth $391.
Loading charts...
Returns By Period
CSL Ltd (CSLLY) has returned -29.20% so far this year and -47.00% over the past 12 months. Over the last ten years, CSLLY has returned 1.53% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.
CSL Ltd
- 1D
- 4.63%
- 1M
- 12.38%
- YTD
- -29.20%
- 6M
- -30.76%
- 1Y
- -47.00%
- 3Y*
- -23.34%
- 5Y*
- -17.12%
- 10Y*
- 1.53%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
CSLLY Monthly Returns History
Based on dividend-adjusted daily data since Nov 19, 2008, CSLLY's average daily return is +0.05%, while the average monthly return is +0.94%. At this rate, an investment would double in approximately 6.2 years.
Historically, 53% of months were positive and 47% were negative. The best month was Nov 2023 with a return of +17.6%, while the worst month was May 2026 at -22.7%. The longest winning streak lasted 11 consecutive months, and the longest losing streak was 7 months.
On a daily basis, CSLLY closed higher 51% of trading days. The best single day was Mar 13, 2020 with a return of +22.0%, while the worst single day was Aug 19, 2025 at -17.2%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 9.29% | -17.22% | -3.36% | -8.23% | -22.73% | 14.19% | -29.20% | ||||||
| 2025 | -1.55% | -5.61% | -2.01% | 1.63% | -0.75% | -0.70% | 9.90% | -20.35% | -4.41% | -12.03% | 5.99% | -5.69% | -32.89% |
| 2024 | 0.99% | -5.38% | 2.14% | -4.97% | 5.19% | 4.51% | 3.58% | 2.21% | -4.58% | -5.09% | -2.01% | -4.70% | -8.71% |
| 2023 | 8.09% | -5.47% | -2.52% | 3.26% | 0.20% | -7.70% | -2.55% | -1.91% | -7.74% | -8.62% | 17.56% | 12.01% | 0.93% |
| 2022 | -12.60% | 2.64% | 5.68% | -4.49% | 2.13% | -5.45% | 10.59% | -1.32% | -8.58% | -2.03% | 14.79% | -4.94% | -6.75% |
| 2021 | -5.53% | -1.36% | -0.87% | 3.07% | 7.23% | -4.97% | 0.05% | 7.13% | -7.68% | 8.58% | -3.74% | -3.31% | -2.97% |
Benchmark Metrics
CSL Ltd has an annualized alpha of 1.68%, beta of 0.84, and R2 of 0.25 versus S&P 500 Index. Calculated based on daily prices since November 19, 2008.
- This stock participated in 79.49% of S&P 500 Index downside but only 69.02% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.25 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 1.68%
- Beta
- 0.84
- R²
- 0.25
- Upside Capture
- 69.02%
- Downside Capture
- 79.49%
Return for Risk
Risk / Return Rank
CSLLY ranks 7 for risk / return — in the bottom 7% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for CSL Ltd (CSLLY) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CSLLY | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.20 | ||
| Sortino ratioReturn per unit of downside risk | -4.31 | ||
| Omega ratioGain probability vs. loss probability | 0.75 | 1.37 | -0.61 |
| Calmar ratioReturn relative to maximum drawdown | -0.76 | 2.78 | -3.55 |
| Martin ratioReturn relative to average drawdown | -1.33 | 12.44 | -13.77 |
Dividends
Dividend History
CSL Ltd provided a 5.31% dividend yield over the last twelve months, with an annual payout of $1.06 per share. The company has been increasing its dividends for 7 consecutive years.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $1.06 | $0.73 | $0.64 | $0.59 | $0.56 | $0.56 | $0.49 | $0.41 | $0.38 | $0.47 | $0.63 | $0.28 |
Dividend yield | 5.31% | 2.53% | 1.45% | 1.21% | 1.14% | 1.05% | 0.89% | 0.85% | 1.18% | 1.72% | 3.45% | 1.46% |
Monthly Dividends
The table displays the monthly dividend distributions for CSL Ltd. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.65 | $0.00 | $0.00 | $0.00 | $0.65 | ||||||
| 2025 | $0.00 | $0.00 | $0.33 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.41 | $0.00 | $0.00 | $0.00 | $0.73 |
| 2024 | $0.00 | $0.00 | $0.27 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.36 | $0.00 | $0.00 | $0.00 | $0.64 |
| 2023 | $0.00 | $0.00 | $0.27 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.32 | $0.00 | $0.00 | $0.00 | $0.59 |
| 2022 | $0.00 | $0.00 | $0.26 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.30 | $0.00 | $0.00 | $0.00 | $0.56 |
| 2021 | $0.00 | $0.00 | $0.26 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.30 | $0.00 | $0.00 | $0.00 | $0.56 |
Dividend Yield & Payout
Dividend Yield
CSL Ltd has a dividend yield of 5.31%, which means its dividend payment is significantly above the market average.
Payout Ratio
CSL Ltd has a payout ratio of 67.99%, which is quite average when compared to the overall market. This suggests that CSL Ltd strikes a balance between reinvesting profits for growth and paying dividends to shareholders.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the CSL Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the CSL Ltd was 69.57%, occurring on Jun 3, 2026. The portfolio has not yet recovered.
The current CSL Ltd drawdown is 63.00%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2026 bear market2026 | -69.57%Jun 2026 | 4y 6mo | — | 4y 7moNov 2021 - now |
2011 bear market2011 | -31.42%Sep 2011 | 5mo 14d | 6mo 28d | 1y 7dApr 2011 - Apr 2012 |
COVID crash2020 | -30.33%Mar 2020 | 29d | 7mo 28d | 8mo 27dFeb 2020 - Nov 2020 |
2010 bear market2010 | -27.49%May 2010 | 1mo 27d | 5mo 12d | 7mo 9dMar 2010 - Nov 2010 |
Rate-hike selloffLate 2018 | -25.66%Dec 2018 | 3mo 28d | 8mo 16d | 1y 9dAug 2018 - Sep 2019 |
Drawdown Indicators
| CSLLY | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.57% | -56.78% | -12.79% |
Max Drawdown (1Y)Largest decline over 1 year | -61.86% | -9.10% | -52.76% |
Max Drawdown (3Y)Largest decline over 3 years | -67.37% | -18.90% | -48.47% |
Max Drawdown (5Y)Largest decline over 5 years | -69.57% | -25.43% | -44.14% |
Max Drawdown (10Y)Largest decline over 10 years | -69.57% | -33.92% | -35.65% |
Current DrawdownCurrent decline from peak | -63.00% | -1.80% | -61.20% |
Average DrawdownAverage peak-to-trough decline | -11.56% | -10.71% | -0.85% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 35.24% | 2.03% | +33.21% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of CSL Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how CSL Ltd is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for CSLLY, comparing it with other companies in the Biotechnology industry. Currently, CSLLY has a P/E ratio of 4.6. This P/E ratio is considered low compared to industry peers, which may suggest that the stock is undervalued or that the company has weaker growth prospects.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for CSLLY compared to other companies in the Biotechnology industry. CSLLY currently has a PEG ratio of 0.7. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for CSLLY relative to other companies in the Biotechnology industry. Currently, CSLLY has a P/S ratio of 0.6. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for CSLLY in comparison with other companies in the Biotechnology industry. Currently, CSLLY has a P/B value of 1.0. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with CSLLY
Add CSL Ltd to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with CSLLY